open access

Vol 83, No 8 (2012)
ARTICLES
Get Citation

Inherited thrombophilia with recurrent pregnancy loss in Turkish women – a real phenomenon?

Necdet Suer, Nigun Tandogan, Pinar Yidiz, Ali Yavuzcan, Gazi Yidiz
Ginekol Pol 2012;83(8).

open access

Vol 83, No 8 (2012)
ARTICLES

Abstract

Objectives: To determine the prevalence and the role of hereditary thrombophilia caused by Factor V Leiden (G1691A), prothrombin G20210A or methylenetetrahydrofolate reductase (MTHFR) C677T gene mutations in recurrent pregnancy loss. Material and methods: One hundred and nine patients, who were admitted to the 3rd Obstetrics and Gynecology Outpatient Clinic in Goztepe Training and Research Hospital between 2006 and 2008, were included into the study. The study group consisted of fi fty-seven patients with a history of 3 miscarriages before 20 weeks of gestation and the control group consisted of forty-seven patients with at least one live birth without any history of miscarriage or pregnancy complications. The maternal blood was evaluated for Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations. Results: No statistically signifi cant diff erence was found between the study and the control groups in terms of the prevalence of Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations (p=0.534/ p=0.452/p=0.656, respectively and p<0.05). Furthermore, the prevalence of multiple gene mutations was not statistically diff erent between the groups (p=0.375 and p<0.05) either. Conclusion: Routine screening for Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations in patients with a history of recurrent pregnancy loss is not recommended in Turkish women.

Abstract

Objectives: To determine the prevalence and the role of hereditary thrombophilia caused by Factor V Leiden (G1691A), prothrombin G20210A or methylenetetrahydrofolate reductase (MTHFR) C677T gene mutations in recurrent pregnancy loss. Material and methods: One hundred and nine patients, who were admitted to the 3rd Obstetrics and Gynecology Outpatient Clinic in Goztepe Training and Research Hospital between 2006 and 2008, were included into the study. The study group consisted of fi fty-seven patients with a history of 3 miscarriages before 20 weeks of gestation and the control group consisted of forty-seven patients with at least one live birth without any history of miscarriage or pregnancy complications. The maternal blood was evaluated for Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations. Results: No statistically signifi cant diff erence was found between the study and the control groups in terms of the prevalence of Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations (p=0.534/ p=0.452/p=0.656, respectively and p<0.05). Furthermore, the prevalence of multiple gene mutations was not statistically diff erent between the groups (p=0.375 and p<0.05) either. Conclusion: Routine screening for Factor V Leiden (G1691A), prothrombin G20210A and MTHFR C677T gene mutations in patients with a history of recurrent pregnancy loss is not recommended in Turkish women.
Get Citation

Keywords

factor V Leiden, MTHFR, Prothrombin, trombophilia

About this article
Title

Inherited thrombophilia with recurrent pregnancy loss in Turkish women – a real phenomenon?

Journal

Ginekologia Polska

Issue

Vol 83, No 8 (2012)

Bibliographic record

Ginekol Pol 2012;83(8).

Keywords

factor V Leiden
MTHFR
Prothrombin
trombophilia

Authors

Necdet Suer
Nigun Tandogan
Pinar Yidiz
Ali Yavuzcan
Gazi Yidiz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl